Showing results (291-300 of 941) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|December 14, 2019
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple SclerosisMichelle Allan, Lindsay Grant
Neurology and Therapy|February 16, 2020
Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII TrialsAngelo Ghezzi, Tanuja Chitnis, Annik K-Laflamme, et al.
Neurology and Therapy|June 12, 2025
Differentiation Between Early and Severe Stages of Dementia in Claims Data Based on Diagnosis, Prescription, and Utilization PatternsMoritz Platen, Maresa Buchholz, Anika Rädke, et al.
Neurology and Therapy|July 18, 2025
Update on the Present and Future Pharmacologic Treatment of Parkinson's DiseaseThomas Müller
Neurology and Therapy|June 16, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USASophia Woodson, Edward J Gettings, Chu-Yueh Guo, et al.
Neurology and Therapy|June 4, 2025
Perampanel as Add-on in Patients Aged ≥ 12 Years with Focal Epilepsy: A Prospective Real-World Observational Study from Southern ChinaXiaoli Shi, Xiangru Lu, Lixia Li, et al.
Neurology and Therapy|October 10, 2025
SGLT-2 Inhibitors in the Prevention and Progression of Neurodegenerative Diseases: A Narrative ReviewPaulina Kostrzewska, Paweł Kuca, Przemysław Witek, et al.
Neurology and Therapy|October 8, 2025
Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 ImmunityAndrea Harrer, Richard F Radlberger, Beate Buchegger, et al.
Neurology and Therapy|November 5, 2025
Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering GroupRaed Alroughani, Elisabeth G Celius, Helen Gray, et al.
Neurology and Therapy|October 23, 2025
Clinical Status, Treatment, and Disease Burden of Generalised Myasthenia Gravis in the Asia-PacificThomas Webb, Mami Kasahara-Kiritani, Keira Herr, et al.
Pageof 95